Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective

被引：23

作者：

Todesco, Eve ^{[1
,2
]}

Mazzola, Alessandra ^{[3
]}

Akhavan, Sepideh ^{[2
,4
]}

Abravanel, Florence ^{[5
,6
]}

Poynard, Thierry ^{[7
,8
,9
]}

Roque-Afonso, Anne-Marie ^{[10
]}

Peytavin, Gilles ^{[11
,12
]}

Marcelin, Anne-Genevieve ^{[1
,2
]}

Calmus, Yvon ^{[3
]}

Lecuyer, Lucien ^{[13
]}

Guillemain, Romain ^{[14
]}

Conti, Filomena ^{[3
]}

机构：

[1] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP,UMRS 1136, Paris, France

[2] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France

[3] UPMC Paris VI, Hop Pitie Salpetriere, AP HP, Unite Med Transplantat Hepat,Hepatogastroenterol, Blvd Hop, Paris, France

[4] UPMC Univ Paris 06, Sorbonne Univ, CIMI Paris UMRS CR7, PVI Team,Inserm,U1135, Paris, France

[5] CHU Toulouse, Hop Purpan, Lab Virol, Natl Reference Ctr Hepatitis E, Toulouse, France

[6] INSERM, Ctr Physiopathol Toulouse Purpan, U1043, Toulouse, France

[7] Grp Hosp Pitie Salpetriere, AP HP, Paris, France

[8] UPMC Univ Paris 06, Sorbonne Univ, UMR S 938, Paris, France

[9] INSERM, Inst Cardiometab & Nutr ICAN, Paris, France

[10] Univ Paris Sud, Hop Paul Brousse, AP HP, INSERM,Virol,U1193, Villejuif, France

[11] Bichat Claude Bernard Hosp, AP HP, Pharmacotoxicol Dept, Paris, France

[12] Univ Paris Diderot, Sorbonne Paris Cite, IAME, INSERM,UMR 1137, Paris, France

[13] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Cardiovasc, Paris, France

[14] Hop Europeen Georges Pompidou, AP HP, Pole Cardiovasc Nephrol Hypertens Diabet, Unite Fonct Transplantat Thorac, Paris, France

来源：

ANTIVIRAL THERAPY | 2018年 / 23卷 / 05期

关键词：

E VIRAL-INFECTION; REPLICATION;

D O I：

10.3851/IMP3227

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Hepatitis E virus (HEV) can induce chronic infections in the case of immunosuppression, which are sometimes not cured with ribavirin. Furthermore, sofosbuvir is a highly potent inhibitor of HCV polymerase and was shown to inhibit HEV genotype-3 replication in vitro. We report here the outcome of sofosbuvir/ribavirin therapy on a chronic HEV infection in a heart transplant recipient non-responder to ribavirin. After 24 weeks, the regimen failed to cure the persistent HEV infection, highlighting the need of therapeutic options for HEV-infected immunosuppressed patients.

引用

页码：463 / 465

页数：3

共 50 条

[21] Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection
Tang, L.
Ward, H.
Kattakuzhy, S.
Wilson, E.
Kottilil, S.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (01) : 21 - 36
[22] Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection
Odolini, Silvia
Lanza, Paola
Spinetti, Angiola
Zaltron, Serena
Urbinati, Lucia
Vavassori, Andrea
Nasta, Paola
Festa, Elena
Gargiulo, Franco
Rodella, Anna
Caruso, Arnaldo
Casari, Salvatore
Castelli, Francesco
Vigano, Mauro
NEW MICROBIOLOGICA, 2017, 40 (03): : 218 - 220
[23] The Prevalence of Hepatitis E Virus Infections and Ribavirin Therapy in Heart Transplant Recipients
Okamura, K.
Nawata, K.
Kimura, M.
Kinoshita, O.
Masuzawa, A.
Yamauchi, H.
Hirata, Y.
Owada, Y.
Oshiro, Y.
Okamoto, H.
Ohkohchi, N.
Ono, M.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S78 - S78
[24] Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
Satsangi, Sandeep
Mehta, Manu
Duseja, Ajay
Taneja, Sunil
Dhiman, Radha K.
Chawla, Yogesh
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 859 - 863
[25] Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection
van der Valk, Marc
Zaaijer, Hans L.
Kater, Arnon P.
Schinkel, Janke
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : 242 - 243
[26] Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
Younossi, Zobair M.
Stepanova, Maria
Zeuzem, Stefan
Dusheiko, Geoffrey
Esteban, Rafael
Hezode, Christophe
Reesink, Hendrik W.
Weiland, Ola
Nader, Fatema
Hunt, Sharon L.
JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 228 - 234
[27] Chronic hepatitis E treatment with ribavirin
Boulestin, A.
VIROLOGIE, 2010, 14 (04) : 303 - 303
[28] Sofosbuvir and Ribavirin: Successful Treatment of Chronic Hepatitis C Virus Infection in a Renal Transplant Recipient With Concomitant Chronic Kidney Disease
Abidali, Hussein
Usta, Yousef
Abidali, Ali
Berry, Andrew C.
Kolli, Geetha
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S367 - S367
[29] Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
Walsh, C. E.
Workowski, K.
Terrault, N. A.
Sax, P. E.
Cohen, A.
Bowlus, C. L.
Kim, A. Y.
Hyland, R. H.
Han, B.
Wang, J.
Stamm, L. M.
Brainard, D. M.
McHutchison, J. G.
von Drygalski, A.
Rhame, F.
Fried, M. W.
Kouides, P.
Balba, G.
Reddy, K. R.
HAEMOPHILIA, 2017, 23 (02) : 198 - 206
[30] Treatment of Chronic Hepatitis with Sofosbuvir in Combination with Ribavirin with or without Pegylated Interferon
Sidhu, Sandeep S.
Malhi, Nirmaljeet
Singh, Rupinder
Gover, Rajiv
Sidhu, Js
Bansal, Ajesh
Goyal, Omesh
Sidhu, Gursewak
Nanda, Vijay
Saluja, Harmeet
Sehgal, Alok
Simran, Sidhu
Kishore, Harsh
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S383 - S383

← 1 2 3 4 5 →